A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...

When Ginny Mason was diagnosed with inflammatory breast cancer in 1994, she never once heard the word “biomarker.” “Back then, all you got was ER and PR [the estrogen receptor and progesterone ...

A tumor marker for pancreatic cancer helps healthcare professionals detect, diagnose, or treat it. However, a person can have high tumor marker levels without having cancer. Tumor markers are ...

Of all the types of breast cancer, triple negative breast cancer (TNBC) is the most aggressive and lacks specific therapies.

Research from the University of Cambridge may be able to start a national screening programme for the common cancer ...

Oncologists face a difficult decision after surgically removing a solid tumor. Some patients harbor residual cancer cells, known as minimal residual disease (MRD), and need additional therapy to avoid ...

May 9 (UPI) --Blood tests could catch as many as half of cancers at an earlier, more treatable stage, a new study says. If conducted every year or every other year, the multi-cancer early detection ...

Abu Dhabi launches a groundbreaking Multi-Cancer Early Detection blood test that identifies early signs of over 50 cancer ...

Patients with womb cancer are not being tested for a genetic condition that increases their chance of developing further cancers, a study has found. Despite NHS guidance, less than half of those ...

A team led by investigators at the Mass General Brigham Cancer Institute has discovered that a particular marker on tumor ...

A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA ...